Are you a robotics manufacturer?
Claim your page to correct your specs and keep your listing current.
MicroPort MedBot (Group) is a robotics company founded 2015, based in China, developing 3 robots primarily in the Surgical / Medical category.
CAPITAL & EVIDENCE
MicroPort MedBot (Group) has no confirmed funding round on file and has 2 cited customers but no deployment on record.
Shipped
2customers cited
named in public sources · no deployment on record
- National Institute of Cardiovascular Diseases (NICVD)· 2024microport.com ↗
- 301 Hospital· 2021ala.associates ↗
A deployment is recorded when a public source names both the customer and the robot, or the maker confirms it. Nothing here counts against MicroPort MedBot (Group).
In Surgical / Medical, CMR Surgical, BD Rowa and Catalia Health have deployment evidence on file.
Add a deployment →Intelligent surgical robotics for vascular intervention and endoscopy
MedBot develops surgical robotic systems including the R-ONE vascular intervention platform and Toumai endoscopic surgical robot. Its products are used in minimally invasive procedures for vascular disease and endoscopic surgery, and the company operates from China with global commercialization activity through its web presence and partner announcements.
Active products
3
RoboIndex
41.40
RoboScore 40.17 + Momentum 1.23
Company facts
- Legal name
- MicroPort MedBot (Group) Co., Ltd.
- HQ
- Shanghai, China
- Founded
- 2015 · 11 yrs
- Website
- www.medbotsurgical.com
RoboScore
40.17 RoboScore + 1.23 Momentum· Speculative — thin evidence
Products 65%, Depth 5%, Evidence 30% set the number, and every rated company has all three. Attention has no weight of its own — it is one of the two things Evidence is built from, and it can only ever add. Activity and Readiness describe the brand but never move it. A value we don't have reads —, never zero. Momentum is independently collected news coverage, worth at most 15 points and never a deduction — a maker we have heard nothing about keeps its full RoboScore. Claiming or paying moves nothing.
6 of 6 factors known. How it's calculated
Milestones
R-ONE received approval in China for market launch.
MedBot said R-ONE obtained NMPA market approval in China.
MicroPort MedBot said R-ONE completed the first robotic coronary angioplasty in China.
MicroPort MedBot and Robocath announced completion of the registration clinical trial for R-ONE in China.
Press coverage
- MicroPort® MedBot™ JV's R-ONE®, the World's First Dual-Finger Grasp Mimic Vascular Intervention Robot, Receives Approval in China
MicroPort MedBot · Feb 2024
- MicroPort® MedBot™ JV's R-ONE™ Vascular Interventional ...
MicroPort MedBot
- R-ONE® has been approved by the NMPA for market launch.
MicroPort MedBot
- Robocath receives NMPA approval for R-One robotic platform in China
Robocath
- MicroPort MedBot Announces the Completion of the First ...
FirstWord Health Tech
- Robocath Announces NMPA Approval for R-One Robotic Platform in ...
Surgical Robotics Technology
In the news
3 events · last 90 days
+1.23momentumof 15 maxMicroPort Medbot Telesurgery Milestone Underscores Expansion Potential for Robotic Surgery Platform
In the news
3 events · last 90 days
Why MicroPort MedBot (Group) has been in the news, across 2 outlets — collected and classified independently, so a maker cannot add to it. It never changes a robot's RoboScore — the evidence half of the RoboIndex — and it can move a robot up a board by at most 15 points.
Public loss record
We read both of China’s national recall registers end to end — 2,426 notices. Four name a robot, all drones. Chinese registers are built around vehicles and household goods, so a blank record is weak evidence either way.
Active products by MicroPort MedBot (Group)
3 shown| # | Category | Key specs | ||||
|---|---|---|---|---|---|---|
| 1 |  | Toumai® MT-1000 Pro | Surgical / Medical | DOF 7 DOF | 2022 | 37.0 |
| 2 |  | R-ONE vascular surgical | Surgical / Medical | — | 2014 | 32.0 |
| 3 | Toumai endoscopic | Surgical / Medical | — | 2014 | 31.6 |
Surgical / Medical buying guides
Industry Knowledge →
Surgical Robot Vendor Selection: Support Coverage, Software Upgrades, and Lifecycle
A surgical robot purchased today will be in your OR for 10–15 years. The support SLA, software upgrade path, end-of-life timeline, and field service model deter…
Pilot to Scale: Case Volume Thresholds for Surgical Robot ROI
Most surgical robot programs break even somewhere between 150 and 400 cases per year depending on platform, procedure mix, and reimbursement. The math is knowab…
Surgeon Training Curve and Proctoring: The 18-Month Onboarding Window
A surgeon's robotic learning curve runs 20–150 cases depending on procedure and prior experience. The proctoring structure, credentialing ladder, and OR efficie…